These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15805796)

  • 21. Angiogenic Imbalance as a Contributor of Preeclampsia.
    Dymara-Konopka W; Laskowska M; Błażewicz A
    Curr Pharm Biotechnol; 2018; 19(10):797-815. PubMed ID: 30255753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New insights in the pathophysiology of preeclampsia and potential therapeutic implications].
    Boulanger H; Flamant M
    Nephrol Ther; 2007 Dec; 3(7):437-48. PubMed ID: 18047998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoadiponectinemia and circulating angiogenic factors in overweight patients complicated with pre-eclampsia.
    Suwaki N; Masuyama H; Nakatsukasa H; Masumoto A; Sumida Y; Takamoto N; Hiramatrsu Y
    Am J Obstet Gynecol; 2006 Dec; 195(6):1687-92. PubMed ID: 16769024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obstetric nephrology: preeclampsia--the nephrologist's perspective.
    Umans JG
    Clin J Am Soc Nephrol; 2012 Dec; 7(12):2107-13. PubMed ID: 23065496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preeclampsia and angiogenic imbalance.
    Maynard S; Epstein FH; Karumanchi SA
    Annu Rev Med; 2008; 59():61-78. PubMed ID: 17937587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia.
    Maynard SE; Venkatesha S; Thadhani R; Karumanchi SA
    Pediatr Res; 2005 May; 57(5 Pt 2):1R-7R. PubMed ID: 15817508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction.
    Crispi F; Domínguez C; Llurba E; Martín-Gallán P; Cabero L; Gratacós E
    Am J Obstet Gynecol; 2006 Jul; 195(1):201-7. PubMed ID: 16545329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Angiogenic proteins: possible markers of physiopathological processes during fetal development].
    Petersen TM; Larsen T; Nielsen HJ
    Ugeskr Laeger; 2003 Aug; 165(32):3082-7. PubMed ID: 12951850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New developments in the pathogenesis of preeclampsia.
    Naljayan MV; Karumanchi SA
    Adv Chronic Kidney Dis; 2013 May; 20(3):265-70. PubMed ID: 23928392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating angiogenic factors in pregnancies complicated by pre-eclampsia.
    Varughese B; Bhatla N; Kumar R; Dwivedi SN; Dhingra R
    Natl Med J India; 2010; 23(2):77-81. PubMed ID: 20925202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia--a step forward but not the definitive answer.
    Foidart JM; Schaaps JP; Chantraine F; Munaut C; Lorquet S
    J Reprod Immunol; 2009 Nov; 82(2):106-11. PubMed ID: 19853925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating angiogenic factors and the risk of preeclampsia.
    Levine RJ; Maynard SE; Qian C; Lim KH; England LJ; Yu KF; Schisterman EF; Thadhani R; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
    N Engl J Med; 2004 Feb; 350(7):672-83. PubMed ID: 14764923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Placental origins of angiogenic dysfunction in mirror syndrome.
    Bixel K; Silasi M; Zelop CM; Lim KH; Zsengeller Z; Stillman IE; Rana S
    Hypertens Pregnancy; 2012; 31(2):211-7. PubMed ID: 22150085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fractional excretion of angiogenic factors in women with severe preeclampsia.
    Buhimschi CS; Magloire L; Funai E; Norwitz ER; Kuczynski E; Martin R; Richman S; Guller S; Lockwood CJ; Buhimschi IA
    Obstet Gynecol; 2006 May; 107(5):1103-13. PubMed ID: 16648417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of nitric oxide, angiogenic growth factors and biochemical analysis in preeclampsia.
    Saha T; Halder M; Das A; Das SK
    Indian J Biochem Biophys; 2013 Oct; 50(5):462-6. PubMed ID: 24772969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Placental-specific sFLT-1: role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosis.
    Palmer KR; Tong S; Kaitu'u-Lino TJ
    Mol Hum Reprod; 2017 Feb; 23(2):69-78. PubMed ID: 27986932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of the mechanism for poor placentation in early-onset preeclampsia: the role of autophagy in trophoblast invasion and vascular remodeling.
    Saito S; Nakashima A
    J Reprod Immunol; 2014 Mar; 101-102():80-88. PubMed ID: 23969229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered angiogenesis in preeclampsia: evaluation of a new test system for measuring placental growth factor.
    Schmidt M; Dogan C; Birdir C; Callies R; Kuhn U; Gellhaus A; Janetzko A; Kimmig R; Kasimir-Bauer S
    Clin Chem Lab Med; 2007; 45(11):1504-10. PubMed ID: 17970705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in understanding of preeclampsia.
    Bdolah Y; Karumanchi SA; Sachs BP
    Croat Med J; 2005 Oct; 46(5):728-36. PubMed ID: 16158464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
    Govender N; Naicker T; Rajakumar A; Moodley J
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.